Print

Ventrus Biosciences, Inc.  (VTUS) to Present at the Lazard Capital Markets 9th Annual Healthcare Conference  
11/9/2012 10:18:59 AM

NEW YORK, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Ventrus Biosciences, Inc. (Nasdaq:VTUS), a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that Dr. Russell Ellison, Chairman and Chief Executive Officer, will be presenting at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13th at 1:30 p.m. Eastern Time at the Pierre Hotel in New York.
//-->